Research & Development: Page 49
-
PharmaVoice Team/PharmaVoice
Tools of the Trade
First Medidata-Sponsored Clinical Trial Assesses Capability of mHealth Tools Trending Now: New study explores potential for providing patients with mobile health tools in a clinical trial setting. Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences,...
By PharmaVoice Team • Sept. 1, 2015 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Healthcare Businesswomen’s Association’s (HBA) Annual Conference — Influence and Impact: Imagine the Possibilities — will take place November 3-5, 2015, at the Marriott Marquis in Atlanta. More than 1,200 executives — women and men — will convene to engage in meaningful dia...
By PharmaVoice Team • Sept. 1, 2015 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotech Pool Dr. Nathalie Adda Enanta Names Chief Medical Officer Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has appointed Nathalie Adda, M.D., as senior VP and chief medical ...
By PharmaVoice Team • Sept. 1, 2015 -
PharmaVoice Team/PharmaVoice
Last Word
A Unique Approach to Regenerative Medicine Karine Kleinhaus, M.D., Divisional VP, North America, Pluristem Therapeutics, discusses how the emerging wave of regenerative and cell therapies could potentially improve the longevity and quality of life of patients living with chronic diseases. PV: Wh...
By Karin Kleinhaus • Sept. 1, 2015 -
PharmaVoice Team/PharmaVoice
Gene Therapy: Delivering on the Promise
It’s been 16 years since tragedy struck in the clinical research world. A patient in an experimental gene therapy trial died just days after receiving the therapy. In 1999, Jesse Gelsinger came to the University of Pennsylvania with a rare metabolic disorder that prevents the body from breaking d...
By Denise Myshko • Sept. 1, 2015 -
PharmaVoice Team/PharmaVoice
C-Suite: Clinical Service
Contract Research Organizations C-Suite executives from some of the industry’s leading CROs provide their insights on where the greatest opportunities lie for improving clinical research operations, the greatest challenges involved with the trial process, and best practices to enhance clinical op...
By Taren Grom • Sept. 1, 2015 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Celebrating Inspiration When we first conceptualized this special issue 11 years ago, the idea was that it would be nice to showcase the people who are having a positive impact on the industry. We didn’t know then that this issue would come to mean so much more than a metaphoric high five. Over t...
By Taren Grom • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Who's on the list by Company
AbelsonTaylor Inc. Keith Stenlund Achillion Pharmaceuticals Kevin Kucharski Advanced Clinical LLC Leo Sheridan Alcobra Pharma David Baker Altasciences Chris Perkin AmerisourceBergen Corp. Marc Kikuchi Artcraft Health Marc Sirockman Astellas Pharma US Inc. Jim Robinson Astr...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
TGaS Advisors Launches Emerging Life Sciences Network Trending Now: The network provides peer support, data, and insights for accelerating commercial success. TGaS Advisors, a benchmarking and advisory services firm for life-sciences commercial organizations, has launched the Emerging Life Scien...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Marcello Agosti Takeda Names Head of New Global Commercial Organization Takeda has named Marcello Agosti head of global commercial, based in Zurich. The company established the global commercial organization as part of its plans to structure operations to become more agile and custome...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
Commanders & Chiefs Dr. Michelle Berrey Chimerix Rob Cosinuke athenahealth and Epocrates Jim Curtis Remedy Health Media Dr. Bruce Feinberg Cardinal Health Specialty Solutions Lisa Giles Giles & Associates Consultancy Inc. and Optivara Inc. Peter Goldschmidt Sandoz Inc. D...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Researchers & Scientists
Dr. Anish Suri Title: Senior Scientific Director, Discovery Immunology Company: Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson Education: Ph.D., Immunology, Washington University St. Louis; B.S., Biology, Angelo State University Famil...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Fun Facts About the PharmaVOICE 100
Where they were born? The PharmaVOICE 100 may come from all over, but what they have in common is a sincere desire to improve the lives of patients everywhere. What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it t...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Overcoming the Challenges that Hinder Innovation
PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovation In a Patient-Centric World
From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In the rare disease community there is saying: Alone we are rare, together we are strong. Wendy White, senior VP, for rare diseases, at Dohmen Life Science Services, a board member of Global Genes, and the president of the Heathcare Businesswomen’s Association (HBA), shared her personal rare dis...
By Taren Grom • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
The 3D Human Body Frank Sculli, Co-founder and CEO of BioDigital, talks about his company’s 3D technology that can produce a virtual model of the human body to help everyone better understand health and disease concepts. The amount and complexity of health information continues to grow, but the w...
By Frank Sculli • June 1, 2015 -
PharmaVoice Team/PharmaVoice
The Network
IBM Partners For Advanced Health Data Collection Trending Now: Apps and partnerships extend medical reach and research. IBM has established a Watson Health Cloud that will provide a secure and open platform for physicians, researchers, insurers, and companies focused on health and wellness soluti...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Wearables in Clinical Trials
Wearables are emerging as a solution for creating a more nimble and efficient clinical trial process, from recruiting patients to collecting real-world patient data. While the movement is still in its infancy and there are several challenges and hurdles to overcome before wearables become commonp...
By Robin Robinson • June 1, 2015 -
PharmaVoice Team/PharmaVoice
The Importance of CROs For Oncology Trials
Oncology trials are different from trials in other therapeutic areas. They are often more complex, involve adaptive design, and can include biomarker and companion diagnostics. They require CROs with therapeutic experience and the knowledge and skills to address these more complex studies. Cancer...
By Denise Myshko • June 1, 2015 -
PharmaVoice Team/PharmaVoice
2015 DIA Preview
The DIA Annual Meeting brings together key thought leaders and innovators from industry, academia, government and regulatory agencies, health, patient, and philanthropic organizations from around the globe and across all disciplines involved in the discovery, development, and life-cycle managemen...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Solutions: Clinical Services Market Poised For Growth
According to a recent report from JZ Med, the global clinical trial service market is expected to reach more than $64 billion by 2020, up from $38.4 billion at present, representing a CAGR of 9% between 2015 and 2020. By 2020 the average clinical trial outsourcing penetration will likely reach ar...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Endpoint-Based Protocol Development: An Outcomes-Based Approach to Clinical Trial Testing
A shift toward more targeted therapeutics, combined with the need to meet specific endpoints in clinical trials, has placed a significant emphasis on esoteric laboratory tests within the test menus employed in clinical trials. Biopharmaceutical companies and clinical research organizations have l...
By Mark Engelhart • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Patient or Partner? Building An Innovative Relationship for the Future
The healthcare industry has struggled with many changes in the last 10 years, including the inevitable patent cliff, the emergence of patient advocacy, increased regulatory and healthcare reform, and the rising cost of doing business. However, even in this age of rapid innovation and adaptability...
By Marc Sirockman • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Implementing Interactive Response Technology in A Software-As-A-Service Model
Historically, the software used in clinical trials has taken the form of either a fully installed customized solution, or a hybrid customized and configurable solution. The implementation of such systems has been time-consuming with costly infrastructure, and because minimizing IT delivery times ...
By Jamey McCarty • June 1, 2015
Previous
